Aureliano Zana obtained his master’s degree in “Pharmaceutical Chemistry and Technology” at the University of Milan on 24/10/19. He joined the research group of Prof. Paola Conti for the master thesis with a project about “Design, synthesis and biological evaluation of 3-bromo isoxazoline covalent inhibitors of glyceraldehyde-3-phosphate dehydrogenase as potential antimalarial agents”. From 15/06/20 works at Philochem AG (Zurich) as a research associate focusing on a project focused on the synthesis of Small-Molecule Drug Conjugates (SMDCs) founded by ETN MagicBullet::Reloaded (Marie Skłodowska-Curie Action) in collaboration with Scuola Universitaria Superiore IUSS Pavia.
The research project is focused on the design and the synthesis of Small-Molecule Drug Conjugates (SMDCs) as anticancer agents. Moreover the project involves biodistribution studies of the payload released from SMDCs and the exploit of targeting agents selective for overexpressed tumor antigens.